Upload
mothersafe
View
785
Download
3
Embed Size (px)
Citation preview
내 용
베이비플랜의 필요성
플랜 되지 않은 임싞
베이비플랜 : 선천성기형예방
마더세이프전문상담센터에서의 베이비플랜
갑상선질환
당뇨병
경련성질환
면역질환
Recent issues in Preconception Care
I. 플랜 되지 않은 임신
0
1
2
3
알코올 흡연 방사선 약물
노출 빈도 (OR)
Han JY et al. Birth Defects Res A Clin Mol Teratol. 2005
Unintended pregnancy : 48%
이소트레티노인 노출 후 임신경과
임신결과 빈도 (%)
출산 31 (39.7)
자연유산 10 (12.8)
인공유산 8 (10.2)
임싞유지 17 (21.7)
추적실패 12 (15.3)
총 78 (100.0%)
[2001-2010.10]
Acitretin 노출
AbstractWe assessed the pregnancy outcome of nine women inadvertently transfused with acitretin-contaminated blood products in South Korea. A total of 18 women matched to cases by age, gravidity, and singleton- or twin-pregnancy, and who were transfused with blood products not contaminated with acitretin, was also recruited. There were nine babies born in the case group. No differences (p > 0.05) were observed between cases and controls in the gestational age at delivery (38.3 +/- 1.6 weeks vs 37.8 +/- 2.2 weeks), birth weight (3,146 +/- 874 g vs 3,106 +/-568 g), rate of pre-term deliveries (22.2% vs 11.1%) and rate of low birth weight (<2,500 g) (33.3% vs 16.7%). There was no case of malformation or neurological abnormalities born in either group. In conclusion, inadvertent exposure to acitretin-contaminated blood products was not associated with adverse pregnancy outcomes, probably because of the removal of acitretin and etretinate during the manufacturing process of blood products.
No specific reason
Previous miscarriage
Bad OB history
Previous abnormal baby
Genetic disease
Paternal chronic disease
N=686
핚국마더세이프젂문상담센터 2010
2004.10~2009.12
베이비플랜을 위해 클리닉 방문한 이유
베이비플랜 여성의 생활양상과 건강상태
Factors USA(%) KMC(%)
Multivitamin use 35.1 50.6 (286/565)
Tobacco use 23.2 5 (28/564)
Alcohol use 50.1 53 (296/559)
Thyroid disease - 3.5 (20/572)
Diabetes 1.8 0.5 (3/572)
Hypertension 6.9 1.2 (7/572)
Autoimmune disease - 0.7 (4/572)
Psychiatric disease - 0.9% (5/572)
한국마더세이프전문상담센터 2010
알코올
태아알코올증후굮(FAS)
• 정싞지체
• 특징적 안면이상
• 성장장애
• Preventabl teratogen
• Leading cause of mental retardation
갑상선질환
Lab. test Frequency
TSH, below 3.9 % (26/659)
TSH, high 3.3 % ( 22/659)
갑상선항진증 : 조산, 임신중독증 성장장애, 사산
갑상선저하증 : 지능저하, 저체중증, 임신중독증, 조기태반박리, 사산
0
1
2
3
4
5
6
7
8
9
1
Counseling
No counseling
All women
Perce
nt o
f M
alfo
rmatio
ns
In diabetic women
Counseling(n=601)
No counseling(n=612)
All women(n=1855)
(Lancet 1992)1.0
8.8
5.6
당뇨병
0.5% (3/572)핚국마더세이프젂문상담센터 2010
고혈압
1.2% (7/572)핚국마더세이프젂문상담센터 2010
ACE inhibitors &
Angiotensin receptor blocker
• 에날라프릴, 캡토프릴, 리시노프릴
• 기형발생위험률(심혈관기형, 중추싞경기형) :2.7배
• 양수과소증 : 태아폐성숙방해, limb contracture 등
자가면역질환시 치료약물
류마티스관젃염, 베쳇질환 등
• NSAIDs
• Corticosteroid
• Hydroxychloroquine
• Methotrexate
• Azathioprine
정신 질환0.9% (5/572)
핚국마더세이프젂문상담센터 2010
우울증 : 선택성세로토닌 재흡수 억제제(SSRIs)
citalopram, escitalopram, fluoxetine,
fluvoxamine, paroxetine, sertraline
조울증 : Lithium : Ebstein’s anomaly 1/148
Drug Abnormalities Affected Catego.
Valproate NTD, Clefts, Skeletal abnormalities, developmental delay1-2% with monotherapy9-12% with polytherapy
D
Phenytoin
Fetal hydantoin sd: craniofacial anomalies, finger nail hypoplasia,Growth deficiency, cardiac defects, clefts, developmental delay
5-11% D
Carbamazepine Fetal hydantoin sd, spina bifida 1-2% D
Phenobarbital Clefts, cardiac anomalies, Urinary tract malformations 10-20% D
LamotrigineInhibits dihydrofolate reductase, lowering fetal folate levels, Registry data suggest increased risk for clefts
4-fold with monotherapy10-fold with polytherapy
C
Topiramate Registry data suggest increased risk for clefts 2% C
LevetriacetamTheoretical-skeletal abnormalities and impaired growth in animals ant doses similar to or greater than human therapeutic doses
Too few cases reported toassess risk
C
간질(Epilepsy) 0.5% (3/572)핚국마더세이프젂문상담센터 2010
만성질환의 임신결과?
임싞젂 상담 : 1,075 례
204 명 : 고혈압, 당뇨병, 싞장질환, 갑상선질환, 천식, 심장질환
임싞결과 (63례):
이젂임싞 : 40% 정상아
다음임싞 : 80% 정상아
(Br J Obstet Gynecol 1992)
정리
플랜 되지 않은 임싞 : 기형우려 물질 노출 2-3배 높음.
기형우려약물 : 약물에 대핚 적젃핚 상담 필요
베이비플랜 : 엽산제 복용 . 계획 임싞률 높여야 함
활성화를 위핚 접근성높고 효율성이 높은 PC
마더세이프젂문상담센터 활용 : ☎ 1588-7309